Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model

Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model

Background Glucagon-like peptide-1 (GLP-1) analogues regulate glucose homeostasis and have anti-inflammatory properties, but cause gastrointestinal side effects. The fibroblast growth factor 21 (FGF21) is a hormonal regulator of lipid and glucose metabolism that has poor pharmacokinetic properties,...

Full description

Bibliographic Details
Main Authors: Jin Hee Kim, Gha Young Lee, Hyo Jin Maeng, Hoyoun Kim, Jae Hyun Bae, Kyoung Min Kim, Soo Lim
Format: Article
Language:English
Published: Academya Publishing Co. 2021-02-01
Series:Endocrinology and Metabolism
Subjects:
glucagon-like peptide 1
fibroblast growth factor 21
atherosclerosis
diabetes mellitus
inflammation
Online Access:http://www.e-enm.org/upload/pdf/enm-2020-781.pdf

Internet

http://www.e-enm.org/upload/pdf/enm-2020-781.pdf

Similar Items